Epac: A Promising Therapeutic Target for Vascular Diseases: A Review

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review

Vascular diseases affect the circulatory system and comprise most human diseases. They cause severe symptoms and affect the quality of life of patients. Recently, since their identification, exchange proteins directly activated by cAMP (Epac) have attracted increasing scientific interest, because of...

Full description

Bibliographic Details
Main Authors:	Yunfeng Pan, Jia Liu, Jiahui Ren, Yun Luo, Xiaobo Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Pharmacology
Subjects:	Epac cAMP vascular disease therapeutic target activator and inhibitor
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.929152/full

Similar Items

EPAC in Vascular Smooth Muscle Cells
by: Nadine Wehbe, et al.
Published: (2020-07-01)

Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
by: Nshunge Musheshe, et al.
Published: (2022-02-01)

cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
by: Muhammad Bilal Ahmed, et al.
Published: (2022-06-01)

The Role of Epac in Cancer Progression
by: Nadine Wehbe, et al.
Published: (2020-09-01)

Role of EPAC1 Signalosomes in Cell Fate: Friends or Foes?
by: Karina Formoso, et al.
Published: (2020-08-01)

The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells
by: Zhengyin Gao, et al.
Published: (2022-01-01)

Epac1 Is Crucial for Maintenance of Endothelial Barrier Function through A Mechanism Partly Independent of Rac1
by: Alexander García-Ponce, et al.
Published: (2020-09-01)

cAMP-Epac1 signaling is activated in DDAVP-induced endolymphatic hydrops of guinea pigs
by: Wang Chuan, et al.
Published: (2023-05-01)

Absence of EPAC1 Signaling to Stabilize CFTR in Intestinal Organoids
by: João F. Ferreira, et al.
Published: (2022-07-01)

GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure
by: Marion Laudette, et al.
Published: (2021-01-01)

Host cell cAMP-Epac-Rap1b pathway inhibition by hawthorn extract as a potential target against Trypanosoma cruzi infection
by: Gabriel Ferri, et al.
Published: (2023-12-01)

Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease
by: Tong Zhang, et al.
Published: (2024-02-01)

Diabetic retinopathy: Involved cells, biomarkers, and treatments
by: Jiahui Ren, et al.
Published: (2022-08-01)

cAMP-Dependent Signaling and Ovarian Cancer
by: Agnieszka Kilanowska, et al.
Published: (2022-11-01)

EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells
by: Charlotte Foret-Lucas, et al.
Published: (2023-01-01)

Emerging Role of cAMP/AMPK Signaling
by: Muhammad Aslam, et al.
Published: (2022-01-01)

Cyclic AMP-Dependent Regulation of Kv7 Voltage-Gated Potassium Channels
by: Jennifer van der Horst, et al.
Published: (2020-06-01)

Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection
by: Muhammad Aslam, et al.
Published: (2020-08-01)

Identification and Characterization of an Affimer Affinity Reagent for the Detection of the cAMP Sensor, EPAC1
by: Hanna K. Buist, et al.
Published: (2021-09-01)

cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
by: Hongying Zhang, et al.
Published: (2024-01-01)

cAMP-Epac Pathway Stimulation Modulate Connexin-43 and MicroRNA-21 Expression in Glioma Cells
by: Hossein Mostafavi, et al.
Published: (2015-02-01)

EPAC2: A new and promising protein for glioma pathogenesis and therapy
by: Seidu A. Richard
Published: (2020-04-01)

Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
by: Yusuke Shiozaki‐Takagi, et al.
Published: (2024-04-01)

Regulation of Mitochondrial Homeostasis by sAC-Derived cAMP Pool: Basic and Translational Aspects
by: Muhammad Aslam, et al.
Published: (2021-02-01)

Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective
by: Alveena Ahmed, et al.
Published: (2019-11-01)

EPAC1 inhibition protects the heart from doxorubicin-induced toxicity
by: Marianne Mazevet, et al.
Published: (2023-08-01)

Multiple Facets of cAMP Signalling and Physiological Impact: cAMP Compartmentalization in the Lung
by: Martina Schmidt, et al.
Published: (2012-11-01)

New insight into gut microbiota and their metabolites in ischemic stroke: A promising therapeutic target
by: Shuxia Zhang, et al.
Published: (2023-06-01)

Behavior and hippocampal Epac signaling to nicotine CPP in mice
by: Liu Jing, et al.
Published: (2019-10-01)

Epac2 in midbrain dopamine neurons contributes to cocaine reinforcement via enhancement of dopamine release
by: Xiaojie Liu, et al.
Published: (2022-08-01)

Role of EPAC1 in chronic pain
by: Chenlu Jiang, et al.
Published: (2024-03-01)

The Role of cAMP in Beta Cell Stimulus–Secretion and Intercellular Coupling
by: Andraž Stožer, et al.
Published: (2021-07-01)

Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling
by: Edward E. Putnins, et al.
Published: (2021-11-01)

An EPAC1/PDE1C-Signaling Axis Regulates Formation of Leading-Edge Protrusion in Polarized Human Arterial Vascular Smooth Muscle Cells
by: Paulina Brzezinska, et al.
Published: (2019-11-01)

Cell-specific expression of Epac2 in the subventricular and subgranular zones
by: Hyunhyo Seo, et al.
Published: (2019-12-01)

Evaluation of Rap1GAP and EPAC1 gene expression in endometriosis disease
by: Mehran Dehghanian, et al.
Published: (2023-01-01)

Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation
by: Bastien Guillot, et al.
Published: (2023-02-01)

Pyruvate Upregulates Hepatic FGF21 Expression by Activating PDE and Inhibiting cAMP–Epac–CREB Signaling Pathway
by: Yan-Yan Zhao, et al.
Published: (2022-05-01)

EPAC1 and EPAC2 promote nociceptor hyperactivity associated with chronic pain after spinal cord injury
by: Samantha C. Berkey, et al.
Published: (2020-01-01)

The therapeutic potential of targeting exchange protein directly activated by cyclic adenosine 3′,5′-monophosphate (Epac) for central nervous system trauma
by: Alba Guijarro-Belmar, et al.
Published: (2021-01-01)